DHTKD1 and cancer: To simulate such hypothetical conditions, we used two CRADs, Ad5-hTERT-E1A-GFP and Ad5F35-hTERT-E1A (hereafter referred to as Ad5-CRAD and Ad5F35-CRAD, respectively), to infect cancer cells at very low MOI.